Middle East & Africa Baby Diaper Market is Expected to Witness the Fastest Growth (9.5% CAGR) Globally During 2016 – 2022

The global baby diaper market is expected to increase from $48.0 billion in 2015, and reach $68.2 billion by 2022, growing at a CAGR of 5.2%. The increasing number of women in workforce, introduction of bio degradable diapers, and increased awareness about personal hygiene and growing population, are some of the factors driving the growth of the global baby diaper market. The emergence of hybrid diapers and presence of untapped markets for baby diapers are expected to give a major boost to the growth of the global baby diaper market in the future. The increasing adoption of G-diapers is expected to boost the growth of the global market, as they have become the preferred choice for mothers, due to their chlorine free and perfume free nature.

Baby diaper Market by P&S Market Research

Baby diaper in the report, primarily refer to diapers worn by infants, and children who experience bedwetting or are not yet toilet trained. On an average, a baby undergoes diaper change 5 or more times a day. The delayed toilet training of children in developed countries, and growing online purchase of baby diapers are some of the trends witnessed in the global market.

Among the various products, the disposable diaper segment dominated the  global market in 2015 by holding a significant amount of market share. In 2015, Europe was the largest baby diaper market. The market in Middle East & Africa is growing at a rapid pace, due to the rapid increasing urbanization in the region.

The major companies operating in the global baby diaper market include Kimberly-Clark Corporation, Procter & Gamble, Unicharm Corporation, Kao Corporation, SVENSKA CELLULOSA AKTIEBOLAGET SCA, Bumkins, Fujian Heng Group Co. Ltd., Bummis Inc., and Nobel Hygiene Pvt. Ltd.

News Courtesy: P&S Market Research

Latin America Shavers Market is Expected to Witness the Fastest Growth (17% CAGR) Globally During 2015 – 2020

The global shavers market is expected to increase from $19,112.9 million in 2014, and reach $29,777.2 million by 2020 at a CAGR of 7.9%. The non-electric shavers market is expected to witness fastest growth during the forecast period. Europe was globally the largest shavers market in 2014; however, Latin America is expected to become the market leader during the forecast period.

shavers market by p&s market research

The increasing urbanization level, growing housing industry, and up surging disposable incomes are the key drivers for the global shavers market. The increasing consciousness about appearance in both men and women are propelling the shavers market growth. A few shifts in trends have been observed in the men and women shaving, which is providing benefits to the shavers market. These trends include body hair removal by men and facial shaving by women. The growing trend of sporting beard is emerging as a market restraint, which is also being encouraged by the athletes and film stars. The underpenetrated rural markets in the developing countries, increasing number of female consumers, and improvement in shaver technology are providing significant growth opportunities to the shaver market during the forecast period.

The trend of body hair removal has been surging in the recent past, owing to the increasing population of metrosexual men. Waxing is one of the common methods of body hair removal; however, it is costlier as compared to shaving. Moreover, with the increase in frequency of body hair removal, the overall cost associated with the waxing service also surges for the consumer. This has led to increase in the usage of shavers for body hair removal.  Also, the comfort level of consumer with shavers is also high, while removing body hair from private parts. According to a recent study published in the Journal of Sexual Medicine, wherein 1,100 male and female students across two universities from U.S. had participated, 95% of the participants agreed that they remove their pubic hair at least once in a week. Approximately 90% of women in Australia and 99% in the U.K. shave their legs and armpits, which is leading to high sales of shavers and epilators from female consumers in these countries.

With the increasing urbanization, the importance of appearance has also become significant, which is consequently fueling the growth of beauty and grooming products. This includes electric and non-electric shavers as well, which are one of the most inherent grooming products in day-to-day life.

Shavers are products related to looks and appearance. This makes celebrity endorsements, a major mode of promotion for the market. Celebrity endorsement has increased at a significant rate during the recent past, in the shavers market. The companies are organizing promotional campaigns for their shaver products with the renowned celebrities, including athletes and film stars. Procter & Gamble has engaged several renowned celebrities and athletes, including Tiger Woods, Roger Federer, David Beckham, Derel Jeter, Thierry Henry, and Matt Ryan, in the recent past for its Gillette brand. The disposable razor segment has been witnessing decline in its market growth, especially in Europe. This is due to the economic recovery in Europe, which is instilling confidence among consumers to re-switch to system razors and electric shavers.

The global shavers market is consolidated in structure, with fewer companies having the hold of large portion of the market. The major companies operating in the global shavers market include Panasonic Corporation, Conair Corporation, Koninklijke Philips N.V., The Procter & Gamble Company, Edgewell Personal Care Company, Spectrum Brands Holdings Inc., Wahl Clipper Corporation, Super-Max Limited, and SOCIETE BIC SA.

News Courtesy: P&S Market Research

Neem Extract Market Trends, Size, Development and Demand Forecast to 2020

The global neem extract market is expected to grow, from an estimated value of $653.7 million in 2015, at a CAGR of 15.9% during 2015 to 2020. The growth is mainly driven by the increasing consumption of bio-based fertilizers and pesticides, especially in Europe. The rejuvenation of ayurveda-based therapy owing to campaigns and advertisements by the domestic ayurvedic companies, such as Patanjali (India), has increased the scope of neem extract in personal care domain. The increase in bio-based animal farming during the past few years is also expected to increase demand for neem extract globally. The increasing consumption of bio-based pesticides and fertilizers in the Asian countries is laying opportunities for the neem extract market. The key restraints for the market include less concentration of neem plantations in non-Asian countries and negative opinion of certain people about the safety profile of neem-based health products.

Neem Extract Market by P&S Market Research

The increasing concern of people and regulatory authorities towards harmful effects of chemical-based fertilizers and pesticides on human health has been compelling the farmers to use bio-based farm products. This has led to a significant increase in the demand for bio-based fertilizers and pesticides. Following the effect, the demand of neem extract based fertilizers and pesticides are also escalating. The demand for organic food has also been increasing in the recent past, especially in Europe, wherein people are preferring products with organic label due to which retailers are increasing the percentage of organic products in their shelves.

Countries such as Spain, France and Denmark have reduced the agricultural chemical usage by about 30%. Among the Asian countries, China is the leading market for bio-based products including neem-extract based fertilizers and pesticides. Australia and India are the other major countries in the region using neem-extract based farm products.

The growing demand for organic food has been escalating the demand for bio based agro-product including neem extract. Several campaigns in North America and Europe against genetically modified crops have been pushing regulatory authorities to encourage organic farming. Neem based agro-products have been gaining significance in western countries, which is being reflected in the increasing market for neem extract. Neem extract is also being used widely to manufacture medicinal and personal care products for human. However, its oral consumption has been interpreted as unsafe by several organizations, and certain countries; such as Canada, have completely banned them. For animal feed and pet care products, neem extract is treated as safe and effective, and it is the key reason behind the growth of this segment.

Neem extract market is highly fragmented with a large number of small players concentrated in specific countries, who distribute their products locally as well as internationally. Most of these companies are located in the Asian countries, which are the largest consumers of neem extract products globally.

News Courtesy: P&S Market Research

 

North America Population Health Management Market Expected to Witness the Fastest Growth Globally, During 2016 – 2022

The global population health management market was valued at $11,114.4 million in 2015, and it is expected to grow at a CAGR of 23.3% during 2016-2022. The cloud based segment in the global population heath management market is expected to witness the fastest growth at a CAGR of 29.1% during the forecast period.

The global population health management market is growing at a significant rate, due to growing geriatric population, regulatory mandate under the Affordable Care Act (ACA), and increasing prevalence of chronic and lifestyle associated diseases. The increasing healthcare cost and incentives, and investment by the federal government for adoption of healthcare information technology are also driving the growth of the global population health management market. However, the factors such as lack of privacy of patient data, lack of skilled professionals, and huge investment in infrastructure requirement are inhibiting the growth of the global market.

population health management mkt

Population health management is the collection of patient data through multiple health information technology resources, to analyze data through which care providers can improve financial, operational, and clinical outcome. It improves the quality, safety, efficiency and cost-effectiveness of the healthcare delivery system.

Geographically, North America dominated the global market of population health management in 2015 and is expected to witness the fastest growth, at a CAGR of 23.5%, during the forecast period. This is due to regulatory mandates under the Affordable Care Act (ACA), increasing prevalence of chronic and lifestyle associated diseases, and growing geriatric population.

Some of the key companies operating in the global population health management market include Cerner Corporation, McKesson Corporation, Allscripts Healthcare Solutions Inc., Wellcentive Inc., Conifer Health Solutions LLC., IBM Corporation, Optum, Inc., and Health Catalyst LLC.

News Courtesy: P&S Market Research

X-Ray Imaging Segment Dominated the Global Diagnostic Imaging Market in 2015

The global diagnostic imaging market was valued at $27,930.5 million in 2015, and it is expected to grow at a CAGR of 4.9% during 2016-2022. Based on type of diagnostic imaging, the x-ray imaging segment dominated the global market in 2015.

The global diagnostic imaging market is growing at a significant rate, due to increasing healthcare expenditure, increasing awareness of early diagnosis, and growing geriatric population. The increasing prevalence of chronic diseases, technological advancement and widening application of diagnostic imaging devices, and improving healthcare infrastructure in developing countries are also driving the growth of the global diagnostic imaging market.

Diagnostic Imaging Market

Diagnostic imaging is a technique and process used to create image of the internal as well as external human body parts for clinical purpose. X-ray, ultrasound, magnetic resonance imaging, computed tomography, single photon emission tomography (SPECT), and positron emission tomography (PET), are some of the major diagnostic imaging techniques.

The factors, such as stringent regulatory requirements, increasing risk of cancer due to exposure of radiation, and shortage of helium gas deposits for magnetic resonance imaging are inhibiting the growth of the global market.

Geographically, North America dominated the global market of diagnostic imaging in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth at a CAGR of 5.7%, during the forecast period.

Some of the key companies operating in the global diagnostic imaging market include Siemens AG, Koninklijke Philips N.V., General Electric Company, Hitachi Ltd., Toshiba Corporation, Shimadzu Corporation, FUJIFILM Holdings Corporation, SAMSUNG, and Esaote SpA.

News Courtesy: P&S Market Research

Asia-Pacific Computed Tomography Market Expected to Witness the Fastest Growth (5.8% CAGR) Globally, During 2016 – 2022

The global computed tomography market was valued at $4,894.3 million in 2015, and it is expected to grow at a CAGR of 5.0% during 2016-2022. Based on slice type, the high slice type segment is expected to witness the faster growth, CAGR of 5.3%, during the forecast period.

The global CT market is growing at a significant rate, due to increasing healthcare expenditure, and growing geriatric population. The increasing prevalence of chronic diseases and improving healthcare infrastructure in developing countries are also driving the growth of the global computed tomography market. However, the factors such as stringent regulatory requirements for the approval of CT devices, and side effects of ionization radiation are inhibiting the growth of the global market.

Computed Tomography Matket

Computed tomography (CT) is an imaging procedure, which uses special x-ray equipment to provide detailed images of internal organs, blood vessels, soft tissues and bones. It is also known as CAT scanning (computerized axial tomography). It provides cross-sectional images in multiple planes. It helps in diagnosis of cancer, circulatory conditions and disorders (coronary artery disease, blood clots, and blood vessel aneurysms), kidney and bladder stone, spinal conditions, inflammatory diseases (ulcerative colitis and sinusitis), and injuries to head, skeletal system and internal organs.

Geographically, North America dominated the global market of CT in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, at a CAGR of 5.8%, during the forecast period.

Some of the key companies operating in the global CT market include Hitachi Ltd., Siemens AG, Toshiba Corporation, Samsung, General Electric Company, and Koninklijke Philips N.V.

News Courtesy: P&S Market Research

Global Mass Spectrometry Market Size, Share, Development and Demand Forecast to 2022

The global mass spectrometry market was valued at $4,948.3 million in 2015, and it is expected to grow at a CAGR of 8.1% during the period 2016 – 2022.The global market is increasing, due to increasing food safety concern, growing demand in life science and clinical analysis sector, and increasing healthcare expenditure and development of healthcare infrastructure.  In addition, the technological advancements with advent of mass spectrometry equipment are further encouraging the growth of the market.

Based on platform, the hybrid mass spectrometry segment accounted for the largest share during the forecast period. Among the various end-users, the pharmaceutical segment accounted for the largest share in the global market in 2015; and the segment is expected to grow at 8.8% CAGR during 2016 – 2022.

Mass Spectrometry Market by P&S Market Research

The demand for mass spectrometry is growing rapidly in life science and clinical sector. Some of its most common applications in life science and clinical studies are determination of protein structure, interactions and folding; protein identification from the mass of its peptide fragment; relative or absolute quantification of proteins in a given sample; monitoring of enzyme reactions; chemical modifications; protein digestion; forensic analysis; and disease biomarkers detection. All these applications are very vital in life science and clinical studies; and with increasing healthcare awareness, advanced research and development, increasing cases of drug abuse, and high number of metabolic diseases, the demand for mass spectrometer is rapidly growing.

However, the lack of skilled professionals act as major restraints in the growth of the global market.  In addition, the high cost mass spectrometry equipment is further restraining the growth of the market. The Asian market is expected to witness the fastest growth, at a CAGR of 8.7% during the period 2016 – 2022.

The key companies operating in the global mass spectrometry market include Danaher Corporation, Shimadzu Corporation, Thermo Fisher Scientific Inc., Bruker Corporation, Agilent Technologies Inc., Waters Corporation, PerkinElmer Inc., LECO Corporation, Dani Instruments S.p.A, Protea Biosciences Group Inc., Microsaic Systems PLC, Endress+Hauser Inc., Jeol USA Inc., and Elico Ltd.

News Courtesy: P&S Market Research

Asia-Pacific Ultrasound Device Market is Expected to Witness the Fastest Growth, a CAGR of 6.3%, During 2016 – 2022

The global ultrasound device market was valued at $6,014.4 million in 2015, and it is expected to grow at a CAGR of 5.5% during 2016-2022.Based on portability of ultrasound, the portable/compact/handheld ultrasound segment is expected to witness the faster growth at a CAGR of 8.8%, during the forecast period.

Ultrasound machine

 

The global ultrasound device market is growing at a significant rate, due to increasing healthcare expenditure, technological advancement of ultrasound, increasing demand for minimally invasive diagnostic and therapeutic techniques, and growing geriatric population. The increasing prevalence of chronic diseases and improving healthcare infrastructure in developing countries are also driving the growth of the global ultrasound device market.

Ultrasound is a sound with frequencies higher than about 20 kHz. It moves in a wavelike manner through which it travels. The waves travel with different speed in different medium. The medical ultrasound system operates at higher frequencies, typically 1-10 MHz.

Ultrasound imaging is a medical imaging technique which uses high frequency sound waves and their echoes. It exposes body parts to high frequency sound waves in order to create images of the internal organs of the body. It does not use ionizing radiation. It provides a real time structure and movement of body’s internal organs and blood flowing through blood vessels. It helps in evaluation of symptoms such as swelling, pain, infection and hematuria. In addition, it is also used for guide procedures such as needle biopsies, guide biopsy of breast and diagnosis of various heart conditions. However, it cannot penetrate mature bones and substantial gas layers.

Stringent regulatory requirements for the approval of ultrasound devices, is inhibiting the growth of the global market. Geographically, Europe dominated the global market of ultrasound device in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, a CAGR of 6.3%, during the forecast period.

Some of the key companies operating in the global ultrasound device market include Siemens AG, Koninklijke Philips N.V., General Electric Company, Hitachi Ltd., Toshiba Corporation, Analogic Corporation, FUJIFILM Holdings Corporation, Mindray Medical International Ltd., and Esaote SpA.

News Courtesy: P&S Market Research

Energy Bars Segment Expected to Lead the Global Sports Food Market During 2016 – 2022

the global sports food market is expected to grow at a CAGR of 9.2% in terms of value during 2016 – 2022. Among the various types, the energy bars segment accounted for the largest share (71.4%) in the global sports food market in 2015.

Sports Food Market by P&S Market Research

The global sports food market has been growing due to factors, such as surging urbanization and growing numbers of fitness centers and health clubs. The consumers in the sports nutrition market tend to move from tastier sports foods to healthier ones. During the course of their purchase of sports food, the consumer keenly looks for the ingredients involved.  The manufacturers are trying to bring about products with the best blend of taste and healthy ingredients. They have started to concentrate on the sugar content in their product offering. The demand for bars with organic ingredient has grown significantly, especially in the developed countries. With the increasing instances of celiac disease, the sports food manufacturers are choosing ingredients such as sunflower seeds, quinoa, brown rice flour, pea and rice protein, tapioca syrup, cacao nibs and organic agave, in order to match the consumer needs.

The developed countries such as the U.S. and countries in Europe, still remain major markets for sports food products; however the emerging economies in Asia-Pacific are expected to be major growth drivers for the market. The low awareness in the developing countries, as compared to the western markets is the key reason for less market share of eastern countries, in the global sports food market. Moreover, the low disposable income of consumers and use of products limited only to athletes and bodybuilders have also been hindering the growth of the global sports food market earlier.

The major companies operating in the global sports food market include Nestle S.A., Clif Bar & Company, Glanbia Plc, Abbott Laboratories, PepsiCo Inc., GNC Holdings Inc., The Coca Cola Company, Universal Food, GlaxoSmithKline Plc, and MusclePharm Corporation.

News Courtesy: P&S Market Research

Global Hepatitis Drugs Industry Analysis, Development and Demand Forecast to 2020

The global hepatitis drugs market was valued at $23,222.1 million in 2014, and it is expected to grow with a CAGR of 29.7% during 2015 – 2020. The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.

Hepatitis Drugs Market

Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest growth during the forecast period, with a CAGR of 30.7%.

 

The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in the growth of the global hepatitis drugs market. According to the Hepatitis B Foundation, a non-profit organization solely dedicated to the global problem of hepatitis B, approximately 400 million people globally were chronically infected with hepatitis B, as reported at the end of September 2015. According to the World Health Organization (WHO), an estimated 130 – 150 million people globally were reported to suffer from hepatitis C, as of July 2015. The increasing incidences of hepatitis have increased the demand of therapeutic drugs for the management of diseases.

However, the high capital expenditure and stringent regulatory requirements are inhibiting the growth of the market. The growing number of collaboration and partnerships is one of the latest trends observed in the market.

Geographically, North America dominated the global market of hepatitis drugs in 2014; whereas the Asian market is expected to witness the fastest growth, with a CAGR of 32.4% during the forecast period.

The key companies operating in the global hepatitis drugs market include Gilead Sciences Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., GlaxoSmithKline PLC, AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, and Mitsubishi Tanabe Pharma Corporation.

News Courtesy: P&S Market Research